Nov 13 - By Associated Press
Eli Lilly & Co. said Friday its science and technology head will retire. The drugmaker hired the chief researcher at AstraZeneca PLC to replace him.
Nov 11 - By Associated Press
Utah has agreed to a $24 million settlement with Eli Lilly & Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa, Utah Attorney General Mark Shurtleff said Wednesday.
Oct 23 - By Meg Kinnard , Associated Press Writer
South Carolina's attorney general said Friday the state has reached a $45 million settlement with drug maker Eli Lilly & Co. over the company's marketing of an anti-psychotic drug, an agreement the drug maker said was its largest with a single state over Zyprexa.

Oct 22 - By Tom Murphy, AP Business Writer
There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.

Oct 21 - By Tom Murphy, AP Business Writer
Eli Lilly & Co. turned a third-quarter profit as sales volume on several drugs climbed, but its newest drug and a possible key source of future revenue started slowly.

Sep 14 - By Marley Seaman, AP Health Writer
Seeking to cut costs and bring new drugs to market more quickly as its best-sellers go off-patent, drugmaker Eli Lilly & Co. said Monday it will eliminate 5,500 jobs over two years and reorganize into five business units.
Aug 18 - By Associated Press
A federal court ruling that invalidated a patent protecting Eli Lilly and Co.'s cancer drug Gemzar surprised at least one analyst covering the company but stirred little reaction from investors in trading Tuesday.
Jul 24 - By Andrew Seligman, AP Sports Writer
The Cubs placed left-hander Ted Lilly on the 15-day disabled list on Saturday because of inflammation in his pitching shoulder.
Jul 22 - By Tom Murphy, AP Business Writer
Eli Lilly and Co.'s second-quarter profit rose 21 percent but the drugmaker's share price lagged Wednesday, as investors wait to learn more about how the company will handle a daunting revenue hole that looms a few years away.
Jul 10 - By Matthew Perrone, AP Business Writer
The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
Jun 3 - By Matthew Perrone, AP Business Writer
Consumer health advocates and a co-developer of a highly anticipated blood thinner from Eli Lilly are calling on the Food and Drug Administration to halt its review of the drug, which they say may be unsafe at the suggested dose.
Apr 20 - By Tom Murphy, AP Business Writer
Drugmaker Eli Lilly and Co. saw its first-quarter profit soar on strong sales but then watched its stock price dip Monday on a rough day for the broader market.
Feb 24 - By Matthew Perrone, AP Business Writer
An influential cardiologist who criticized an experimental Eli Lilly drug should not have been barred from a panel that evaluated the drug's safety, federal health officials said.
Feb 5 - By Tom Murphy, AP Business Writer
Former Eli Lilly & Co. Chairman and Chief Executive Sidney Taurel saw his total pay flatten out during his last year on the job, but retirement nest eggs totaling more than $40 million are waiting for him, according to regulatory filings.
Feb 3 - By Matthew Perrone, AP Business Writer
A panel of government health experts said Tuesday a highly anticipated Eli Lilly blood thinner marks a significant advance over older treatments and should be approved.

Feb 2 - By Lauri Neff, Associated Press Writer
If you thought the tortured tropical romance between Sawyer and Kate was over, you might be surprised by a future episode of "Lost," according to Evangeline Lilly, who stars as Kate on the ABC thriller.
Jan 30 - By Associated Press
The U.S. Attorney's Office for the Eastern District of Pennsylvania says drugmaker Eli Lilly & Co. formally pleaded guilty to a misdemeanor tied to the marketing of its top-seller, the anti-psychotic Zyprexa.
Jan 30 - By Matthew Perrone, AP Business Writer
Federal health officials said Friday a blood thinner from Eli Lilly offers life-saving benefits over drugs currently on the market, though its use may have to be restricted due to bleeding side effects.
Jan 29 - By Tom Murphy, AP Business Writer
Drugmaker Eli Lilly & Co. beat Wall Street's fourth-quarter expectations Thursday, but analysts say they're waiting for a regulatory hearing next week to gauge the company's near-term health.

Jan 15 - By Tom Murphy, AP Business Writer
Eli Lilly & Co. taught its sales force a catchy slogan to peddle the antipsychotic drug Zyprexa for treating the elderly.
Jan 14 - By Associated Press
Drugmaker Eli Lilly and Co. is close to agreeing to a $1.4 billion settlement related to a government investigation into the marketing of its top seller Zyprexa, according to a New York Times report.
Dec 11 - By Tom Murphy, AP Business Writer
Eli Lilly and Co. said Thursday its $6.5 billion ImClone acquisition will wipe out its 2008 profit and dent next year's earnings as well.
Nov 28 - By Associated Press
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.
Oct 23 - By Tom Murphy, AP Business Writer
Fresh off the biggest deal in company history, drugmaker Eli Lilly and Co. may not be done shopping, Chief Executive John Lechleiter said Thursday.
Oct 21 - By Tom Murphy, AP Business Writer
Eli Lilly and Co. will take a big bite out of its third-quarter earnings with a $1.4 billion charge related to a government investigation over marketing practices for the anti-psychotic Zyprexa.